![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/28/2905768/0/en/Eliem-Therapeutics-Announces-its-Addition-to-the-Russell-2000-and-Russell-3000-Indexes.html
https://www.globenewswire.com/news-release/2024/06/27/2905516/0/en/Eliem-Therapeutics-Announces-the-Closing-of-its-Acquisition-of-Tenet-Medicines-and-Concurrent-120-Million-Private-Placement.html
https://www.globenewswire.com/news-release/2024/04/11/2861368/0/en/Eliem-Therapeutics-Announces-Agreement-to-Acquire-Tenet-Medicines-and-Concurrent-120-Million-Private-Placement.html
https://www.fiercebiotech.com/biotech/eliem-knows-it-takes-two-tango-dancing-away-closure-new-acquisition
https://www.globenewswire.com/news-release/2023/07/20/2708024/0/en/Eliem-Therapeutics-Announces-Plans-to-Explore-Strategic-Alternatives.html
https://www.fiercebiotech.com/biotech/eliem-shuts-down-final-drug-program-five-months-after-major-layoffs
https://www.globenewswire.com/news-release/2023/05/11/2667335/0/en/Eliem-Therapeutics-Reports-First-Quarter-Financial-Results-and-Business-Highlights.html
https://www.globenewswire.com/news-release/2023/03/06/2621558/0/en/Eliem-Therapeutics-Reports-Fourth-Quarter-and-Year-End-Financial-Results-and-Business-Highlights.html
https://www.fiercebiotech.com/biotech/eliem-drops-depression-drug-ending-pursuit-biogen-sage-and-lays-55-team-stretch-cash-2027
https://www.globenewswire.com/news-release/2023/02/09/2605470/0/en/Eliem-Therapeutics-Provides-Strategic-Update-and-Announces-Leadership-Transition.html